Meeting of the Community Preventive Services Task Force (Task Force), 21238-21239 [2017-09133]
Download as PDF
<![CDATA[
21238
Federal Register / Vol. 82, No. 86 / Friday, May 5, 2017 / Notices
Request for Comments
In accordance with the Paperwork
Reduction Act, comments on AHRQ’s
information collection are requested
with regard to any of the following: (a)
Whether the proposed collection of
information is necessary for the proper
performance of AHRQ health care
research and health care information
dissemination functions, including
whether the information will have
practical utility; (b) the accuracy of
AHRQ’s estimate of burden (including
hours and costs) of the proposed
collection(s) of information; (c) ways to
enhance the quality, utility and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Sharon B. Arnold,
Acting Director.
[FR Doc. 2017–09097 Filed 5–4–17; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Meeting of the Community Preventive
Services Task Force (Task Force)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
The Centers for Disease
Control and Prevention (CDC) within
the Department of Health and Human
Services announces the next meeting of
the Community Preventive Services
Task Force (Task Force) on June 14–15,
2017 in Atlanta, Georgia.
DATES: The meeting will be held on
Wednesday, June 14, 2017 from 8:30
a.m. to 6:00 p.m. EDT and Thursday,
June 15, 2017 from 8:30 a.m. to 1:00
p.m. EDT.
ADDRESSES: The Task Force Meeting
will be held at the CDC Edward R.
Roybal Campus, Centers for Disease
Control and Prevention Headquarters
(Building 19), 1600 Clifton Road NE.,
Atlanta, GA 30329. You should be
aware that the meeting location is in a
SRADOVICH on DSK3GMQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:43 May 04, 2017
Jkt 241001
Federal government building; therefore,
strict Federal security measures are
applicable. For additional information,
please see Roybal Campus Security
Guidelines under SUPPLEMENTARY
INFORMATION. Information regarding
meeting logistics will be available on
the Community Guide Web site
(www.thecommunityguide.org) closer to
the date of the meeting.
Meeting Accessability: This spacelimited meeting is open to the public.
All meeting attendees must register to
ensure completion of required security
procedures and access to the CDC’s
Global Communications Center.
Public Comment: A public comment
period, limited to three minutes per
person, will follow the Task Force’s
discussion of each systematic review.
Individuals wishing to make public
comments must indicate their desire to
do so in advance by providing their
name, organizational affiliation, and the
topic to be addressed (if known) with
their registration. Public comments will
become part of the meeting summary.
Public comment is not possible via
Webcast.
U.S. citizens must register by June 7,
2017. To satisfy security requirements,
Non U.S. citizens must register by May
29, 2017. Failure to register by the dates
identified could result in the inability to
attend the Task Force meeting.
Meeting Accessibility: This meeting is
available to the public via Webcast. CDC
will send the Webcast URL to registrants
upon receipt of their registration. All
meeting attendees must register to
receive the webcast information. CDC
will email webcast information from the
CPSTF@cdc.gov mailbox.
FOR FURTHER INFORMATION/REGISTRATION,
CONTACT: Onslow Smith, Center for
Surveillance, Epidemiology and
Laboratory Services, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE., MS–E–69, Atlanta, GA 30329,
phone: (404) 498–6778, email: CPSTF@
cdc.gov.
SUPPLEMENTARY INFORMATION:
Background on the CPSTF: The Task
Force is an independent, nonpartisan,
nonfederal, and unpaid panel. Its
members represent a broad range of
research, practice, and policy expertise
in prevention, wellness, health
promotion, and public health, and are
appointed by the CDC Director. The
Task Force was convened in 1996 by the
Department of Health and Human
Services (HHS) to identify community
preventive programs, services, and
policies that increase healthy longevity,
save lives and dollars, and improve
Americans’ quality of life. CDC is
mandated to provide ongoing
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
administrative, research, and technical
support for the operations of the Task
Force. During its meetings, the Task
Force considers the findings of
systematic reviews on existing research
and practice-based evidence and issues
recommendations. Task Force
recommendations are not mandates for
compliance or spending. Instead, they
provide information about evidencebased options that decision makers and
stakeholders can consider when they are
determining what best meets the
specific needs, preferences, available
resources, and constraints of their
jurisdictions and constituents. The Task
Force’s recommendations, along with
the systematic reviews of the evidence
on which they are based, are compiled
in the Guide to Community Preventive
Services (The Community Guide).
At the meetings, the Task Force
considers systematic reviews and issues
findings and recommendations based on
the reviews. Task Force
recommendations provide information
about evidence-based options that
decision makers and stakeholders can
consider when they are determining
what best meets the specific needs,
preferences, available resources, and
constraints of their jurisdictions and
constituents.
Matters proposed for discussion*:
Diabetes prevention: Diabetes
Prevention and Control (Effectiveness of
Mobile Phone Applications to Improve
Glycemic Control (HbA1c) in the Selfmanagement of Diabetes); Obesity
Prevention and Control (Economics of
School-based Interventions for Obesity
Prevention Availability of Healthy Food
and Beverage (AHFB) and Snack Food
and Beverage (SFB)); Physical Activity
(Effectiveness of Activity Monitors for
Increasing Physical Activity in Adults
with Overweight or Obesity); Nutrition
(Telehealth Methods to Deliver Dietary
Interventions in Adults with Chronic
Disease); and Women’s Health
(Effectiveness of Interventions for the
Primary Prevention of Intimate Partner
Violence and Sexual Violence Among
Youth). The agenda is subject to change
without notice.
Roybal Campus Security Guidelines:
The Edward R. Roybal Campus is the
headquarters of the CDC and is located
at 1600 Clifton Road NE., Atlanta,
Georgia. The meeting is being held in a
Federal government building; therefore,
Federal security measures are
applicable.
All meeting attendees must RSVP by
the dates outlined under Meeting
Accessability. In planning your arrival
time, please take into account the need
to park and clear security. All visitors
must enter the Edward R. Roybal
E:\FR\FM\05MYN1.SGM
05MYN1
21239
Federal Register / Vol. 82, No. 86 / Friday, May 5, 2017 / Notices
Campus through the front entrance on
Clifton Road. Vehicles may be searched,
and the guard force will then direct
visitors to the designated parking area.
Upon arrival at the facility, visitors must
present government-issued photo
identification (e.g., a valid federal
identification badge, state driver’s
license, state non-driver’s identification
card, or passport). Non-United States
citizens must complete the required
security paperwork prior to the meeting
date and must present a valid passport,
visa, Permanent Resident Card, or other
type of work authorization document
upon arrival at the facility. All persons
entering the building must pass through
a metal detector. CDC Security
personnel will issue a visitor’s ID badge
at the entrance to Building 19. Visitors
may receive an escort to the meeting
room. All items brought to HHS/CDC
are subject to inspection.
Dated: May 2, 2017.
Sandra Cashman,
Executive Secretary, Centers for Disease
Control and Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket Number CDC–2017–0048, NIOSH
156–C]
Request for the Technical Review of 4
Draft Immediately Dangerous to Life or
Health (IDLH) Value Profile Documents
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Request for information and
comments.
AGENCY:
The National Institute for
Occupational Safety and Health of the
Centers for Disease Control and
Prevention announces four (4) draft
Immediately Dangerous to Life or Health
(IDLH) Value Profile documents now
available for public comment.
SUMMARY:
Table of Contents
[FR Doc. 2017–09133 Filed 5–4–17; 8:45 am]
Dates
Addresses
For Further Information Contact
Supplementary Information
Background
Reference
DATES: Electronic or written comments
must be received by June 19, 2017.
ADDRESSES: You may submit responses,
identified by CDC–2017–0048 and
BILLING CODE 4163–18–P
Document #
B–01
B–02
B–03
B–04
Chemical
.......................................................
.......................................................
.......................................................
.......................................................
SRADOVICH on DSK3GMQ082PROD with NOTICES
1. Does this document clearly outline
the health hazards associated with acute
(or short-term) exposures to the
chemical? If not, what specific
information is missing from the
document?
2. Are the rationale and logic behind
the derivation of an IDLH value for a
specific chemical clearly explained? If
17:43 May 04, 2017
Jkt 241001
CAS
Acetonitrile ............................................................................................................
Chloroacetonitrile ..................................................................................................
Methacrylonitrile ....................................................................................................
Nitrogen dioxide ....................................................................................................
Each IDLH Value Profile document
provides a detailed summary of the
health hazards of acute exposures to
high airborne concentrations and the
rationale for the proposed IDLH value
with the chemical(s) of interest.
To facilitate the review of these
documents, NIOSH requests that the
following questions be taken into
consideration:
VerDate Sep<11>2014
docket number NIOSH 156–C, by any of
the following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: National Institute for
Occupational Safety and Health, NIOSH
Docket Office, 1090 Tusculum Avenue,
MS C–34, Cincinnati, Ohio 45226–1998.
Instructions: All information received
in response to this notice must include
the agency name and docket number
[CDC–2017–0048; NIOSH 156–C]. All
relevant responses received will be
posted without change to
www.regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or information received, go
to www.regulations.gov. All information
received in response to this notice will
also be available for public examination
and copying at the NIOSH Docket
Office, 1150 Tusculum Avenue, Room
155, Cincinnati, OH 45226–1998.
FOR FURTHER INFORMATION CONTACT: G.
Scott Dotson, NIOSH, Education and
Information Division, 1090 Tusculum
Avenue, C–32, Cincinnati, OH 45226,
telephone (513) 533–8540 (not a toll free
number).
SUPPLEMENTARY INFORMATION: NIOSH
seeks comments on four (4) draft IDLH
values and IDLH Value Profile
documents. The draft IDLH Value
Profile documents were developed to
provide the scientific rationale behind
derivation of IDLH values for the
following chemicals:
not, what specific information is needed
to clarify the basis of the IDLH value?
3. Are the conclusions supported by
the data?
4. Are the tables clear and
appropriate?
5. Is the document organized
appropriately? If not, what
improvements are needed?
6. Are you aware of any scientific data
reported in governmental publications,
databases, peer-reviewed journals, or
other sources that should be included
within this document?
Background: In 2013, NIOSH
published Current Intelligence Bulletin
(CIB) 66—Derivation of Immediately
Dangerous to Life or Health (IDLH)
Values [NIOSH 2013]. Since the
establishment of the IDLH values in the
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
(#
(#
(#
(#
75–05–8)
107–14–2)
126–98–7)
10102–44–0)
1970s, NIOSH has continued to review
available scientific data to improve the
protocol used to derive acute exposure
guidelines, in addition to the chemicalspecific IDLH values. The information
presented in this CIB represents the
most recent update of the scientific
rationale and the methodology (hereby
referred to as the IDLH methodology)
used to derive IDLH values. The
primary objectives of this document are
to:
1. Provide a brief history of the
development of IDLH values
2. Update the scientific bases and risk
assessment methodology used to
derive IDLH values from quality
data
E:\FR\FM\05MYN1.SGM
05MYN1
]]>Agencies
[Federal Register Volume 82, Number 86 (Friday, May 5, 2017)]
[Notices]
[Pages 21238-21239]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-09133]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Meeting of the Community Preventive Services Task Force (Task
Force)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) within
the Department of Health and Human Services announces the next meeting
of the Community Preventive Services Task Force (Task Force) on June
14-15, 2017 in Atlanta, Georgia.
DATES: The meeting will be held on Wednesday, June 14, 2017 from 8:30
a.m. to 6:00 p.m. EDT and Thursday, June 15, 2017 from 8:30 a.m. to
1:00 p.m. EDT.
ADDRESSES: The Task Force Meeting will be held at the CDC Edward R.
Roybal Campus, Centers for Disease Control and Prevention Headquarters
(Building 19), 1600 Clifton Road NE., Atlanta, GA 30329. You should be
aware that the meeting location is in a Federal government building;
therefore, strict Federal security measures are applicable. For
additional information, please see Roybal Campus Security Guidelines
under SUPPLEMENTARY INFORMATION. Information regarding meeting
logistics will be available on the Community Guide Web site
(www.thecommunityguide.org) closer to the date of the meeting.
Meeting Accessability: This space-limited meeting is open to the
public. All meeting attendees must register to ensure completion of
required security procedures and access to the CDC's Global
Communications Center.
Public Comment: A public comment period, limited to three minutes
per person, will follow the Task Force's discussion of each systematic
review. Individuals wishing to make public comments must indicate their
desire to do so in advance by providing their name, organizational
affiliation, and the topic to be addressed (if known) with their
registration. Public comments will become part of the meeting summary.
Public comment is not possible via Webcast.
U.S. citizens must register by June 7, 2017. To satisfy security
requirements, Non U.S. citizens must register by May 29, 2017. Failure
to register by the dates identified could result in the inability to
attend the Task Force meeting.
Meeting Accessibility: This meeting is available to the public via
Webcast. CDC will send the Webcast URL to registrants upon receipt of
their registration. All meeting attendees must register to receive the
webcast information. CDC will email webcast information from the
CPSTF@cdc.gov mailbox.
FOR FURTHER INFORMATION/REGISTRATION, CONTACT: Onslow Smith, Center for
Surveillance, Epidemiology and Laboratory Services, Centers for Disease
Control and Prevention, 1600 Clifton Road NE., MS-E-69, Atlanta, GA
30329, phone: (404) 498-6778, email: CPSTF@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background on the CPSTF: The Task Force is an independent,
nonpartisan, nonfederal, and unpaid panel. Its members represent a
broad range of research, practice, and policy expertise in prevention,
wellness, health promotion, and public health, and are appointed by the
CDC Director. The Task Force was convened in 1996 by the Department of
Health and Human Services (HHS) to identify community preventive
programs, services, and policies that increase healthy longevity, save
lives and dollars, and improve Americans' quality of life. CDC is
mandated to provide ongoing administrative, research, and technical
support for the operations of the Task Force. During its meetings, the
Task Force considers the findings of systematic reviews on existing
research and practice-based evidence and issues recommendations. Task
Force recommendations are not mandates for compliance or spending.
Instead, they provide information about evidence-based options that
decision makers and stakeholders can consider when they are determining
what best meets the specific needs, preferences, available resources,
and constraints of their jurisdictions and constituents. The Task
Force's recommendations, along with the systematic reviews of the
evidence on which they are based, are compiled in the Guide to
Community Preventive Services (The Community Guide).
At the meetings, the Task Force considers systematic reviews and
issues findings and recommendations based on the reviews. Task Force
recommendations provide information about evidence-based options that
decision makers and stakeholders can consider when they are determining
what best meets the specific needs, preferences, available resources,
and constraints of their jurisdictions and constituents.
Matters proposed for discussion*: Diabetes prevention: Diabetes
Prevention and Control (Effectiveness of Mobile Phone Applications to
Improve Glycemic Control (HbA1c) in the Self-management of Diabetes);
Obesity Prevention and Control (Economics of School-based Interventions
for Obesity Prevention Availability of Healthy Food and Beverage (AHFB)
and Snack Food and Beverage (SFB)); Physical Activity (Effectiveness of
Activity Monitors for Increasing Physical Activity in Adults with
Overweight or Obesity); Nutrition (Telehealth Methods to Deliver
Dietary Interventions in Adults with Chronic Disease); and Women's
Health (Effectiveness of Interventions for the Primary Prevention of
Intimate Partner Violence and Sexual Violence Among Youth). The agenda
is subject to change without notice.
Roybal Campus Security Guidelines: The Edward R. Roybal Campus is
the headquarters of the CDC and is located at 1600 Clifton Road NE.,
Atlanta, Georgia. The meeting is being held in a Federal government
building; therefore, Federal security measures are applicable.
All meeting attendees must RSVP by the dates outlined under Meeting
Accessability. In planning your arrival time, please take into account
the need to park and clear security. All visitors must enter the Edward
R. Roybal
[[Page 21239]]
Campus through the front entrance on Clifton Road. Vehicles may be
searched, and the guard force will then direct visitors to the
designated parking area. Upon arrival at the facility, visitors must
present government-issued photo identification (e.g., a valid federal
identification badge, state driver's license, state non-driver's
identification card, or passport). Non-United States citizens must
complete the required security paperwork prior to the meeting date and
must present a valid passport, visa, Permanent Resident Card, or other
type of work authorization document upon arrival at the facility. All
persons entering the building must pass through a metal detector. CDC
Security personnel will issue a visitor's ID badge at the entrance to
Building 19. Visitors may receive an escort to the meeting room. All
items brought to HHS/CDC are subject to inspection.
Dated: May 2, 2017.
Sandra Cashman,
Executive Secretary, Centers for Disease Control and Prevention.
[FR Doc. 2017-09133 Filed 5-4-17; 8:45 am]
BILLING CODE 4163-18-P
